Iron oxide nanomaterial is a typical example of a magnetic resonance imaging probe for negative contrast. It has also been shown how this nanomaterial can be synthesized for positive contrast by modification of the composition and size of the core. However, the role of the organic coating in the relaxometric properties is largely unexplored. Here, maghemite nanoparticles with either excellent positive or very good negative contrast performance are obtained by modifying coating thickness while the core is kept unchanged. Different nanoparticles with tailored features as contrast agent according to the coating layer thickness have been obtained in a single-step microwave-driven synthesis by heating at different temperatures. A comprehensive analysis is conducted of how the composition and structure of the coating affects the final magnetic, relaxometric, and imaging performance. These results show how the organic coating plays a fundamental role in the intrinsic relaxometric parameters of iron oxide-based contrast media.
Synthesizing iron
oxide nanoparticles for positive contrast in
magnetic resonance imaging is the most promising approach to bring
this nanomaterial back to the clinical field. The success of this
approach depends on several aspects: the longitudinal relaxivity values,
the complexity of the synthetic protocol, and the reproducibility
of the synthesis. Here, we show our latest results on this goal. We
have studied the effect of Cu doping on the physicochemical, magnetic,
and relaxometric properties of iron oxide nanoparticles designed to
provide positive contrast in magnetic resonance imaging. We have used
a one-step, 10 min synthesis to produce nanoparticles with excellent
colloidal stability. We have synthesized three different Cu-doped
iron oxide nanoparticles showing modest to very large longitudinal
relaxivity values. Finally, we have demonstrated the in vivo use of
these kinds of nanoparticles both in angiography and targeted molecular
imaging.
Iron oxide nanoparticles have been extensively utilised as negative (T2) contrast agents in magnetic resonance imaging. In the past few years, researchers have also exploited their application as positive (T1) contrast agents to overcome the limitation of traditional Gd3+ contrast agents. To provide T1 contrast, these particles must present certain physicochemical properties with control over the size, morphology and surface of the particles. In this review, we summarise the reported T1 iron oxide nanoparticles and critically revise their properties, synthetic protocols and application, not only in MRI but also in multimodal imaging. In addition, we briefly summarise the most important nanoparticulate Gd and Mn agents to evaluate whether T1 iron oxide nanoparticles can reach Gd/Mn contrast capabilities.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.